NSE filing, NSE: SENORES. Summary written from the filing by ALFA Finder's alert engine.
Senores Pharmaceuticals Ltd: key numbers
- Share price
- ₹1,294.80
- Market cap
- ₹5,963 Cr
- Revenue (annual)
- ₹632.6 Cr
- Net profit (annual)
- ₹115.4 Cr
- P/E (TTM)
- 47.2×Sector 46.1×
- Promoter holding
- 45.82%+0.00% QoQ
- FII holding
- 6.01%Current quarter
Reference market data from a third-party provider, updated daily. Not a valuation or a recommendation.
More from Senores Pharmaceuticals Ltd
All →Senores Pharmaceuticals Investor Presentation: Key Takeaways
Q2 FY27 revenue ₹192.3 Cr (+24.9%), EBITDA ₹57.7 Cr (+38.3%, 30.0% margin), PAT ₹36.6 Cr. H1 revenue +30%, EBITDA +58.2%.
Senores Pharmaceuticals Capacity Expansion: ₹43 Cr Investment
Senores Pharmaceuticals disclosed capacity expansion at three subsidiaries with total estimated cost of ₹43 Crore. Expansions adding ~1.5 Bn units/annum are expected by March 2027.
- Value
- ₹43.00 Cr
- Execution
- By end of March 2027
- manufacturing capacity addition (per annum)
- 1502.7 Mn units
Senores Pharmaceuticals Q2 FY27 Results: Net Profit ₹36.6 Cr, Up 21.6% YoY
Senores Pharmaceuticals Ltd reported revenue from operations of ₹192.3 Cr (+25.0% YoY) and net profit of ₹36.6 Cr (+21.6% YoY) for Q2 FY27.
- Key figure
- Net profit ₹36.6 Cr · +21.6% YoY
Senores Pharmaceuticals Board Meeting Date
Senores Pharmaceuticals has scheduled a board meeting for October 29, 2026, to approve its unaudited financial results for the quarter and half-year ended September 30, 2026.
Senores Pharmaceuticals Annual General Meeting
Senores Pharmaceuticals Limited has issued a Postal Ballot Notice seeking shareholder approval for the re-appointment of its Managing Director and Whole Time Director. The e-voting period concludes on November 17, 2026.
Senores Pharmaceuticals Management Change
Senores Pharmaceuticals re-appointed Swapnil Shah as MD and Chetan Shah as WTD for three-year terms. Both appointments are subject to shareholder approval via postal ballot.
Other results update announcements
All →Dwarikesh Sugar Industries Results Update
Dwarikesh Sugar posted a Q2 FY27 loss of ₹13.12 crore, improved from the prior-year quarter. Crushing for the 2026-27 season is set to begin in November.
Wheels India Results Update
Wheels India reported Q2 FY27 net profit of ₹53.4 Crore and revenue of ₹1,598 Crore, up 36% YoY. The company completed a ₹430 Crore fund raise.
Ambuja Cements Results Update
Ambuja Cements posted Q2 FY27 consolidated revenue of Rs 9,197 Cr with EBITDA of Rs 1,271 Cr. The firm commissioned 4.6 MTPA of new capacity amid headwinds.
- cement manufacturing capacity
- 4.6 MTPA
Vishal Nirmiti Results Update
Vishal Nirmiti reported Q1 FY27 revenue of ₹869.7 Cr (up 35%) and PAT of ₹68.8 Cr. Order book stands at ₹5,516.7 Cr.
GK Energy Results Update
GK Energy reported Q2 FY27 revenue of ₹402.65 Crore and PAT of ₹49.36 Crore with 19,391 systems installed. H1 FY27 PAT grew 30.7% Y-o-Y to ₹109.04 Crore.
Shadowfax Technologies Results Update
Shadowfax reported Q2 FY27 revenue of ₹1,538 Cr, up 56.6% YoY, with PAT at ₹68 Cr. Sixth consecutive 55%+ growth quarter, Adj. EBITDA margin at 5.0%.